(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -37.10%27.8M | -178.98%-29.3M | -43.39%137.5M | -107.80%-5.2M | -8.36%61.4M | -22.46%44.2M | -28.93%37.1M | 91.71%242.9M | 104.16%66.7M | 1,850.72%67M |
Net income from continuing operations | 93.62%-300K | 68.71%-9.7M | -2,212.17%-399.2M | -1,259.84%-338.6M | -13.18%-24.9M | -125.00%-4.7M | -165.96%-31M | -74.42%18.9M | -1,140.04%-24.9M | -739.53%-22M |
Operating gains losses | 116.67%2.2M | -97.56%900K | -407.94%-64M | -716.00%-102M | -67.72%14.3M | -1,200.00%-13.2M | 180.92%36.9M | 76.09%-12.6M | -163.15%-12.5M | 563.07%44.3M |
Depreciation and amortization | -6.17%21.3M | 5.94%23.2M | 14.69%96.8M | 11.44%26.3M | 24.52%25.9M | 12.94%22.7M | 10.05%21.9M | 3.18%84.4M | 14.64%23.6M | 4.13%20.8M |
Asset impairment expenditure | ---- | ---- | 659.27%417.6M | ---- | ---- | ---- | ---- | --55M | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | ---5M | ---5.9M | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Remuneration paid in stock | -115.63%-500K | -48.00%1.3M | 46.51%6.3M | 37.50%-1M | 23.08%1.6M | 10.34%3.2M | 47.06%2.5M | 4,200.00%4.3M | -74.86%-1.6M | 257.96%1.3M |
Deferred tax | --0 | --0 | -771.05%-51M | -273.03%-33.2M | -11.43%-7.8M | -112.82%-1M | -157.32%-9M | -62.56%7.6M | -10,570.59%-8.9M | -715.11%-7M |
Other non cashItems | -27.20%17.4M | -5.21%20M | 52.06%99.6M | 94.58%32.3M | 40.25%22.3M | 35.80%23.9M | 37.01%21.1M | 1.39%65.5M | 92.75%16.6M | -1.33%15.9M |
Change In working capital | -192.48%-12.3M | -1,032.08%-60M | 88.38%37.3M | -103.61%-700K | 118.98%30M | 216.67%13.3M | -178.95%-5.3M | 132.30%19.8M | 243.87%19.4M | 127.21%13.7M |
-Change in receivables | ---- | ---- | 360.99%73.6M | ---- | ---- | ---- | ---- | 58.10%-28.2M | ---- | ---- |
-Change in inventory | ---- | ---- | -384.42%-37.3M | ---- | ---- | ---- | ---- | 57.22%-7.7M | ---- | ---- |
-Change in prepaid assets | ---- | ---- | 112.66%2M | ---- | ---- | ---- | ---- | -15.33%-15.8M | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | -101.40%-1M | ---- | ---- | ---- | ---- | 89.66%71.5M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -37.10%27.8M | -178.98%-29.3M | -43.39%137.5M | -107.80%-5.2M | -8.36%61.4M | -22.46%44.2M | -28.93%37.1M | 91.71%242.9M | 104.16%66.7M | 1,850.72%67M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 78.81%-11M | 398.19%297M | 105.11%14.3M | 292.41%256.1M | -63.00%-90.3M | 24.34%-51.9M | -342.67%-99.6M | -1,512.12%-279.6M | -230.45%-133.1M | -229.94%-55.4M |
Capital expenditure reported | 77.40%-21.7M | 92.37%-8.1M | 16.23%-292.6M | 53.67%-51.2M | 56.04%-39.3M | ---96M | ---106.1M | ---349.3M | ---110.5M | ---89.4M |
Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -377.27%-10.5M | ---- | ---- |
Net investment purchase and sale | --0 | ---- | 15.22%-46.8M | -171.32%-147.6M | 0.00%3.8M | 97.40%-400K | ---- | -1,050.00%-55.2M | -1,803.43%-54.4M | 696.55%3.8M |
Net other investing changes | -75.96%10.7M | 4,593.85%305.1M | 161.23%353.7M | 975.41%454.9M | -281.46%-54.8M | 42.63%44.5M | -84.85%6.5M | -5.71%135.4M | 356.56%42.3M | 62.85%30.2M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 78.81%-11M | 398.19%297M | 105.11%14.3M | 292.41%256.1M | -63.00%-90.3M | 24.34%-51.9M | -342.67%-99.6M | -1,512.12%-279.6M | -230.45%-133.1M | -229.94%-55.4M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -196.11%-27.2M | -632.29%-255.5M | -545.12%-168.7M | -459.32%-254.4M | 150.81%9.4M | 62.64%28.3M | 250.94%48M | 126.96%37.9M | 3,129.53%70.8M | -200.15%-18.5M |
Net issuance payments of debt | -136.70%-20M | -472.64%-241.1M | -510.11%-73M | -353.09%-225M | 138.14%32.8M | 57.97%54.5M | 430.10%64.7M | 108.03%17.8M | 611.37%88.9M | 24.74%-86M |
Net common stock issuance | --100K | ---400K | -100.11%-100K | --0 | -100.11%-100K | --0 | --0 | -41.84%87M | 72.22%-100K | -41.92%87.1M |
Cash dividends paid | --0 | --0 | -17.24%-17M | 0.00%-4.3M | -26.47%-4.3M | -23.53%-4.2M | -23.53%-4.2M | -6.62%-14.5M | -25.58%-4.3M | -0.21%-3.4M |
Interest paid (cash flow from financing activities) | 50.45%-10.9M | -12.00%-14M | -50.00%-78.6M | -83.21%-25.1M | -17.28%-19M | -60.58%-22M | -42.05%-12.5M | 4.55%-52.4M | -23.98%-13.7M | -17.10%-16.2M |
Net other financing activities | --3.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -196.11%-27.2M | -632.29%-255.5M | -545.12%-168.7M | -459.32%-254.4M | 150.81%9.4M | 62.64%28.3M | 250.94%48M | 126.96%37.9M | 3,129.53%70.8M | -200.15%-18.5M |
Net cash flow | ||||||||||
Beginning cash position | 392.00%12.3M | -99.41%100K | 7.59%17M | -71.43%3.6M | 18.46%23.1M | -81.75%2.5M | 7.59%17M | 59.60%15.8M | -51.12%12.6M | -30.16%19.5M |
Current changes in cash | -150.49%-10.4M | 184.14%12.2M | -1,508.33%-16.9M | -179.55%-3.5M | -182.61%-19.5M | 255.17%20.6M | -590.48%-14.5M | -79.66%1.2M | 144.24%4.4M | -221.68%-6.9M |
End cash Position | -91.77%1.9M | 392.00%12.3M | -99.41%100K | -99.41%100K | -71.43%3.6M | 18.46%23.1M | -81.75%2.5M | 7.59%17M | 7.59%17M | -51.12%12.6M |
Free cash from | 111.78%6.1M | 45.80%-37.4M | -45.77%-155.1M | -28.77%-56.4M | 198.66%22.1M | -89.05%-51.8M | -439.06%-69M | -1,174.75%-106.4M | -270.72%-43.8M | 41.86%-22.4M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data